quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:33:10·70d
SECFiling
Agios Pharmaceuticals Inc. logo

SEC Form 10-K filed by Agios Pharmaceuticals Inc.

AGIO· Agios Pharmaceuticals Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • AGIO
    Agios Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 20UpdateH.C. Wainwright$50.00
  • Nov 24UpdateTruist-
  • Nov 20UpdateLeerink Partners$34.00
  • Nov 19UpdateRBC Capital Mkts$28.00
  • Feb 24UpdateH.C. Wainwright$58.00
  • Oct 16UpdateScotiabank-

Related

  • ANALYST3d
    H.C. Wainwright reiterated coverage on Agios Pharma with a new price target
  • INSIDER17d
    SEC Form 4 filed by Burns James William
  • INSIDER17d
    SEC Form 4 filed by Gheuens Sarah
  • INSIDER17d
    SEC Form 4 filed by Jones Cecilia
  • INSIDER17d
    SEC Form 4 filed by Milanova Tsveta
  • INSIDER17d
    SEC Form 4 filed by Viswanadhan Krishnan
  • INSIDER17d
    SEC Form 4 filed by Goff Brian
  • PR17d
    Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022